Sonora Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$134K Buy
1,637
+178
+12% +$16K 0.02% 258
2021
Q2
$133K Buy
1,459
+326
+29% +$29K 0.02% 244
2021
Q1
$97K Buy
1,133
+149
+15% +$13.4K 0.01% 420
2020
Q4
$93K Buy
984
+179
+22% +$15.6K 0.01% 430
2020
Q3
$70K Buy
805
+30
+4% +$2.6K 0.01% 473
2020
Q2
$68K Sell
775
-231
-23% -$19.9K 0.01% 416
2020
Q1
$83K Buy
1,006
+252
+33% +$22.5K 0.01% 348
2019
Q4
$71K Sell
754
-392
-34% -$35.2K 0.01% 416
2019
Q3
$100K Buy
1,146
+297
+35% +$26.7K 0.01% 345
2019
Q2
$78K Buy
849
+246
+41% +$20.8K 0.01% 394
2019
Q1
$52K Buy
603
+68
+13% +$5.46K 0.01% 467
2018
Q4
$41K Buy
535
+259
+94% +$20.2K 0.01% 439
2018
Q3
$21K Buy
276
+167
+153% +$12.3K ﹤0.01% 627
2018
Q2
$7K Sell
109
-370
-77% -$25.5K ﹤0.01% 912
2018
Q1
$34.7K Buy
479
+427
+821% +$32.5K 0.01% 452
2017
Q4
$3.95K Sell
52
-173
-77% -$13.1K ﹤0.01% 983
2017
Q3
$17.3K Buy
+225
New +$17K ﹤0.01% 569
2016
Q4
Sell
-112
Closed -$7.9K 862
2016
Q3
$7.9K Hold
112
﹤0.01% 631
2016
Q2
$8.25K Hold
112
﹤0.01% 624
2016
Q1
$7.65K Sell
112
-44
-28% -$2.99K ﹤0.01% 682
2015
Q4
$12K Hold
156
﹤0.01% 484
2015
Q3
$13K Buy
+156
New +$13.9K ﹤0.01% 413

Other funds holding NVS

Sonora Investment Management's NVS Position: Q3 2021 in Review

Sonora Investment Management increased its Novartis (NVS) stake by 12% in Q3 2021, buying an estimated $16K and bringing the position to 1,637 shares worth $134K. The position accounts for 0.02% of the portfolio, ranked #258.

Sonora Investment Management first reported a position in NVS in Q3 2015 and has held it in 22 quarters since. 1,081 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

  • Sonora Investment Management held 1,637 shares of Novartis worth $134K as of Q3 2021.
  • Sonora Investment Management bought 178 Novartis shares in Q3 2021, an estimated $16K.
  • Novartis made up 0.02% of Sonora Investment Management's portfolio in Q3 2021, its #258 holding.
  • Sonora Investment Management first reported a position in Novartis in Q3 2015 and has held it in 22 quarters since.
  • 1,081 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.